.jpg)
Zoledronic Acid for Nonmalignant Painful Bone Marrow Lesions
How to Cite
OrthoEvidence. Zoledronic Acid for Nonmalignant Painful Bone Marrow Lesions. ACE Report. 2022;231(1):1. Available from: https://myorthoevidence.com/AceReport/Report/14583
Efficacy of Zoledronic Acid in the Treatment of Nonmalignant Painful Bone Marrow Lesions: A Triple-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial (ZoMARS)
J Bone Miner Res. 2022 Mar;37(3): 420-427.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
48 patients with painful bone marrow lesions were randomized to receive Vitamin D and calcium supplementation plus a single dose of intravenous Zoledronic acid (n=34) or placebo (n=14). The primary outcome of interest was the change in volume/size of the lesion. Secondary outcomes of interest included pain on a Visual Analog Scale (VAS), pain disability index (PDI), bone-specific quality of life q...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!


Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.
LEARN MORE
Please Login or Join to leave comments.